For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

King's College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer : a proof-of-concept trial

Type
D - Journal article
Title of journal
The Lancet
Article number
-
Volume number
376
Issue number
9737
First page of article
245
ISSN of journal
0140-6736
Year of publication
2010
URL
-
Number of additional authors
14
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
B - Cancer
Citation count
287
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-